Another research team similarly found that administering SR8278 (an antagonist targeting REV-ERBα) via local microinjection into the ventral tegmental area (VTA) at dawn had antidepressant and anti-anxiety effects in mice with 6-OHDA lesions. The gene discussed is NR1D1; the disease is Anxiety.